Nexgel (NXGL) Other Non-Current Liabilities (2018 - 2024)
Nexgel (NXGL) reported Other Non-Current Liabilities of $178000.0 for Q4 2024, down 59.45% on a YoY basis from $439000.0 in Q1 2024, and down 34.32% quarter-over-quarter from $271000.0 in Q3 2024.
Nexgel (NXGL) Other Non-Current Liabilities (2018 - 2024) Analysis & Trends
Nexgel has reported Other Non-Current Liabilities for 3 years, with the latest figure at $178000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Non-Current Liabilities fell 59.45% year-over-year to $178000.0; the trailing twelve-month figure through Dec 2024 stood at $178000.0 (down 59.45% YoY), and the FY2024 full-year result was $178000.0, down 59.45% from the prior year.
- Other Non-Current Liabilities for Q4 2024 stood at $178000.0, down from $271000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $439000.0 in Q4 2023, with the low at $178000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nexgel | 4.18 Mn | 2.81 Mn | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 178,000.00 |
| Sep 30, 2024 | 271,000.00 |
| Jun 30, 2024 | 370,000.00 |
| Mar 31, 2024 | 439,000.00 |
| Dec 31, 2023 | 439,000.00 |
| Dec 31, 2018 | 51,000.00 |